Bicalutamide - Prostate cancer
You are here : Home > Formulary Search > Bicalutamide - Prostate cancer
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Evidence Review
PAD Profile
ChemicalSubstance :
Bicalutamide
Indication :
Prostate cancer
Group Name :
Keywords :
Brand Names Include :
Casodex
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Bicalutamide is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Prostate cancer.
Committee Recommendations (1)
GENERIC Bicalutamide has been considered by the PCN and has been assigned a BLUE traffic light status. Note added January 2025 - this drug should be prescribed on recommendation from a specialist.
NOTE - the branded product, Casodex, was considered BLACK at the PCN in May 2017.